Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026)
Revolution Medicines (RVMD) posted quarterly Other Non Operating Income of $117000.0 for Q1 2026, up 1270.0% year-over-year from $8540.1 in Q1 2025, and down 99.8% quarter-over-quarter from $58.1 million in Q4 2025.
Revolution Medicines (RVMD) Other Non Operating Income (2024 - 2026) Analysis & Trends
Revolution Medicines' Other Non Operating Income history runs 3 years deep, the most recent figure standing at $117000.0 for Q1 2026.
- In Q1 2026, Other Non Operating Income rose 1270.0% year-over-year to $117000.0; the TTM figure through Mar 2026 stood at $58.3 million (up 2410.67% YoY), while the FY2025 annual figure was $58.1 million, changed N/A from the prior year.
- Other Non Operating Income for Q1 2026 stood at $117000.0, down from $58.1 million in the prior quarter.
- The five-year high for Other Non Operating Income was $58.1 million in Q4 2025, with the low at -$2.8 million in Q1 2024.
- The 3-year median for Other Non Operating Income is $66500.0 (2024), against an average of $9.3 million.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income soared 99.64% in 2025, then soared 1270.0% in 2026.
- Revolution Medicines' Other Non Operating Income stood at $282000.0 in 2024, then surged by 20518.79% to $58.1 million in 2025, then slumped by 99.8% to $117000.0 in 2026.
- Business Quant data shows RVMD's Other Non Operating Income at $117000.0 in Q1 2026, $58.1 million in Q4 2025, and -$10000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | 117,000.00 |
| Dec 31, 2025 | 58.15 Mn |
| Mar 31, 2025 | -10,000.00 |
| Sep 30, 2024 | 282,000.00 |
| Jun 30, 2024 | 16,000.00 |
| Mar 31, 2024 | -2.81 Mn |